Mehmet Ozen

About doctor Mehmet Ozen

Mehmet Özen is a leading Turkish hematologist with over 17 years of experience in the diagnosis and treatment of blood diseases. The doctor currently works at Istinye University Gaziosmanpasa Medical Park Hospital in Istanbul, where he heads the Department of Hematology and Bone Marrow Transplantation.

Dr. Mehmet Ozen specializes in the treatment of hematologic malignancies, including leukemia, lymphoma, multiple myeloma, and thalassemia. The doctor has extensive experience in performing various types of stem cell transplantation: allogeneic, autologous, and haploidentical. His clinical interests also include plasmapheresis and other modern therapeutic methods.

In addition to his clinical practice, Dr. Özen is actively involved in scientific research. Mehmet Ozen is the author and co-author of numerous scientific publications focused on modern approaches to the treatment of hematological diseases and stem cell transplantation. Dr. Ozen regularly speaks at international conferences and seminars, sharing his experience and knowledge with colleagues around the world.

Professional experience

• 2010 – Internal Medicine Specialist at Ankara Oncology Hospital;
• 2010 – Assistant, Hematology Department, Ankara Oncology Hospital;
• 2014 – Hematology specialist at Evliya Çelebi Training and Research Hospital, Kutahya Dumlupınar University;
• 2016 – Lecturer at the Faculty of Medicine at Ufuk University, Department of Hematology;
• 2018 – Lecturer at Hitit University Faculty of Medicine, Department of Hematology;
• 2018 – Physician in the Department of Hematology and Bone Marrow Transplantation at Bahçelievler Medical Park;
• 2019 – Assistant attending physician, Bayindir Sogutozu Hospital, Department of Hematology and Stem Cell Transplantation;
• 2022 – Head of the Hematology Department, Afyonkarahisar University of Health Sciences.

Doctor’s specialty

The main areas of scientific and practical activity of Dr. Mehmet Ozen include:

• bone marrow transplant;
• leukemia;
• lymphoma;
• multiple myeloma;
• thalassemia;
• bone marrow diseases;
• plasmapheresis.